DUBLIN--(BUSINESS WIRE)--The "Healthcare Analytical Testing Services Market by Type (Method Validation, Environmental Monitoring, Bioanalytical Services, Stability, Raw Materials, & Microbial Testing), End User (Pharmaceutical, Medical Device Companies) - Global Forecast to 2023" report has been added to ResearchAndMarkets.com's offering.
The Healthcare Analytical Testing Services Market is Expected to Reach USD 5.97 Billion by 2023 from an Estimated USD 3.43 Billion in 2018, at a CAGR of 11.7%.
The shift of focus towards analytical testing of biologics and biosimilars, increasing outsourcing of analytical testing by pharmaceutical companies, increasing acceptance of the QbD approach in pharma research/manufacturing, and adoption of FTE contracts in R&D outsourcing are the major factors driving the growth of the healthcare analytical testing services market.
However, factors such as the pricing pressure faced by market players and shortage of skilled professionals in the healthcare analytical testing services industry are limiting the adoption of healthcare analytical testing services up to some extent during the forecast period.
North America held the largest share of the global healthcare analytical testing services market in 2017. On the other hand, the APAC region is expected to witness the highest CAGR during the forecast period, due to the increasing R&D funding, growing number of CROs, and favorable government initiatives to promote pharmaceutical and biopharmaceutical industries in several APAC countries.
Key Topics Covered:
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Industry Insights
7 Healthcare Analytical Testing Services Market, By Type
8 Healthcare Analytical Testing Services Market, By End User
9 Healthcare Analytical Testing Services Market, By Region
10 Competitive Landscape
11 Company Profiles
- Charles River
- Envigo
- Eurofins Scientific
- Exova
- Intertek
- Labcorp
- MPI Research
- Merck KGaA
- Pace Analytical
- Pharmaceutical Product Development, LLC (PPD)
- SGS
- Source Bioscience
- Wuxi Pharmatech
For more information about this report visit https://www.researchandmarkets.com/research/ng6kvl/healthcare?w=4
